Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Patrick Mahaffey
Pharma
Will Clovis be the next PARP maker to get swallowed up?
Clovis is facing several challenges that have biopharma experts speculating it will be snapped up by an asset-hungry Big Pharma player.
Arlene Weintraub
Dec 7, 2018 10:32am
Clovis' Rubraca joins 'three-horse' race
Apr 9, 2018 12:26pm
With FDA priority review, Clovis eyes big new use for Rubraca
Dec 6, 2017 10:15am
ESMO: Clovis CEO hopes to hone Rubraca edge with new Ariel data
Sep 8, 2017 5:52am
